These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 17915814)

  • 1. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    AAPS PharmSciTech; 2007 Aug; 8(3):E64. PubMed ID: 17915814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of chitosan-alginate as alternative pelletization aid to microcrystalline cellulose in extrusion/spheronization.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    J Pharm Sci; 2007 Sep; 96(9):2469-84. PubMed ID: 17286294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Weerapol Y; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate-based pellets prepared by extrusion/spheronization: a preliminary study on the effect of additive in granulating liquid.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2007 Aug; 67(1):227-35. PubMed ID: 17276664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
    Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-kaolin coprecipitate as disintegrant in microcrystalline cellulose-based pellets elaborated by extrusion-spheronization.
    Goyanes A; Souto C; Martínez-Pacheco R
    Pharm Dev Technol; 2013 Feb; 18(1):137-45. PubMed ID: 22309024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of к-carrageenan, chitosan and Carbopol 974P in extruded and spheronized pellets that are devoid of MCC.
    Valle BL; Omwancha WS; Neau SH; Wigent RJ
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1903-16. PubMed ID: 27100683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preparation by extrusion/spheronization and the properties of pellets containing drugs, microcrystalline cellulose and glyceryl monostearate.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Eur J Pharm Sci; 2005 Jan; 24(1):35-48. PubMed ID: 15626576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coated chitosan pellets containing rutin intended for the treatment of inflammatory bowel disease: in vitro characteristics and in vivo evaluation.
    Rabišková M; Bautzová T; Gajdziok J; Dvořáčková K; Lamprecht A; Pellequer Y; Spilková J
    Int J Pharm; 2012 Jan; 422(1-2):151-9. PubMed ID: 22079717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of sodium alginate on physical and dissolution properties of Surelease-matrix pellets prepared by a novel pelletizer.
    Kim MS; Kim JS; Hwang SJ
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1631-4. PubMed ID: 17978525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative extrusion-spheronization aids.
    Jain SP; Singh PP; Amin PD
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1364-76. PubMed ID: 20521907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of MCC II fraction and storage conditions on pellet properties.
    Krueger C; Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1039-45. PubMed ID: 23872176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. I. Influence of type and fraction of filler.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):59-67. PubMed ID: 16326085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiunit controlled-release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin.
    Mitrevej A; Sinchaipanid N; Rungvejhavuttivittaya Y; Kositchaiyong V
    Pharm Dev Technol; 2001 Aug; 6(3):385-92. PubMed ID: 11485180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New co-processed MCC-based excipient for fast release of low solubility drugs from pellets prepared by extrusion-spheronization.
    Goyanes A; Martínez-Pacheco R
    Drug Dev Ind Pharm; 2015 Mar; 41(3):362-8. PubMed ID: 24279425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan and sodium alginate-based bioadhesive vaginal tablets.
    El-Kamel A; Sokar M; Naggar V; Al Gamal S
    AAPS PharmSci; 2002; 4(4):E44. PubMed ID: 12646014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained-release alginate-chitosan pellets prepared by melt pelletization technique.
    Wong TW; Nurulaini H
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1417-27. PubMed ID: 22309449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and Coating of Alginate and Alginate-Hydroxypropylcellulose Pellets Containing Ranolazine.
    Segale L; Mannina P; Giovannelli L; Muschert S; Pattarino F
    J Pharm Sci; 2016 Nov; 105(11):3351-3358. PubMed ID: 27653554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.